Codexis Inc. (NASDAQ:CDXS) shares surged 37.8% in after-hours trading on Wednesday to $1.75, following the company’s fourth-quarter and full-year 2025 earnings release.
Q4 Profit Swing and Revenue Beat
Codexis reported fourth-quarter net income of $9.6 million, or 11 cents per share, reversing a $10.4 million loss, or 13 cents per share, in the same period a year earlier.
Total fourth-quarter revenue increased 81% to $38.9 million, up from $21.5 million in the same quarter of 2024. The figure topped the analyst estimate of $36.82 million by 5.69%.
The biotechnology company also reported a product gross margin of 65% for the quarter, up from 63% a year earlier.
Full-Year Results and 2026 Outlook
Codexis’ full-year fiscal 2025 revenues rose 19% …